位置:首页 > 产品库 > Venlafaxine HCl(Wy 45030 HCl)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Venlafaxine HCl(Wy 45030 HCl)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Venlafaxine HCl(Wy 45030 HCl)图片
CAS NO:99300-78-4
规格:≥98%
包装与价格:
包装价格(元)
100mg询价
250mg询价
500mg询价
1g询价
2g询价
5g询价
10g询价

理化性质和储存条件
Molecular Weight (MW)313.86
FormulaC17H27NO2·HCl
CAS No.99300-78-4
Storage-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)DMSO: 55 mg/mL (176.8 mM)
Water: 55 mg/mL (176.8 mM)
Ethanol: 55 mg/mL (176.8 mM)
Other info

Chemical Name: 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol hydrochloride

InChi Key: QYRYFNHXARDNFZ-UHFFFAOYSA-N

InChi Code: InChI=1S/C17H27NO2.ClH/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14;/h7-10,16,19H,4-6,11-13H2,1-3H3;1H

SMILES Code: OC1(C(C2=CC=C(OC)C=C2)CN(C)C)CCCCC1.[H]Cl

SynonymsWy-45030; Trade names: Effexor, Effexor XR, Lanvexin, Viepax and Trevilor. Wy45030; Wy 45030;
实验参考方法
In Vitro

In vitro activity: Venlafaxine has a low potential to inhibit the metabolism of substrates for CYP2D6 such as imipramine and desipramine compared with several of the most widely used SSRIs, as well as the metabolism of substrates for several of the other major human hepatic P450s. Venlafaxine inhibits binding to the human norepinephrine (NE) and serotonin (5-HT) transporters with K(i) values of 2480 nM and 82 nM, respectively, and with a K(i) ratio of 30. Venlafaxine has ED(50) values of 5.9 mg/kg and 94 mg/kg for blocking p-chloramphetamine- and 6-hydroxydopamine-induced monoamine depletion, respectively.

In VivoVenlafaxine induces a dose-dependent antinociceptive effect following i.p. administration with an ED50 of 46.7 mg/kg in mice. Venlafaxine-induced antinociception is significantly inhibited by naloxone, nor-BNI and naltrindole but not by beta-FNA or naloxonazine, implying involvement of kappa1- and delta-opioid mechanisms in mice. Venlafaxine reverses hyperalgesia in rats with a fully developed neuropathic lesion. Venlafaxine also appears to have a mild non-specific analgesic effect that increased paw withdrawal latency (PWL) in the sham limb.
Animal modelMice
Formulation & Dosage46.7 mg/kg; i.p.
References

Br J Clin Pharmacol. 1997 Jun;43(6):619-26; Pain. 1996 Nov;68(1):151-5.

 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024